United States Insomnia Drugs Market Report 2017

United States Insomnia Drugs Market Report 2017

1 Insomnia Drugs Overview

1.1 Product Overview and Scope of Insomnia Drugs

1.2 Classification of Insomnia Drugs by Product Category

1.2.1 United States Insomnia Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)

1.2.2 United States Insomnia Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016

1.2.3 Prescription Drugs

1.2.4 Over-the-counter Drugs

1.3 United States Insomnia Drugs Market by Application/End Users

1.3.1 United States Insomnia Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)

1.3.2 Hospital

1.3.3 Ambulatory Surgical Center

1.3.4 Home Care

1.4 United States Insomnia Drugs Market by Region

1.4.1 United States Insomnia Drugs Market Size (Value) Comparison by Region (2012-2022)

1.4.2 The West Insomnia Drugs Status and Prospect (2012-2022)

1.4.3 Southwest Insomnia Drugs Status and Prospect (2012-2022)

1.4.4 The Middle Atlantic Insomnia Drugs Status and Prospect (2012-2022)

1.4.5 New England Insomnia Drugs Status and Prospect (2012-2022)

1.4.6 The South Insomnia Drugs Status and Prospect (2012-2022)

1.4.7 The Midwest Insomnia Drugs Status and Prospect (2012-2022)

1.5 United States Market Size (Value and Volume) of Insomnia Drugs (2012-2022)

1.5.1 United States Insomnia Drugs Sales and Growth Rate (2012-2022)

1.5.2 United States Insomnia Drugs Revenue and Growth Rate (2012-2022)

2 United States Insomnia Drugs Market Competition by Players/Suppliers

2.1 United States Insomnia Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)

2.2 United States Insomnia Drugs Revenue and Share by Players/Suppliers (2012-2017)

2.3 United States Insomnia Drugs Average Price by Players/Suppliers (2012-2017)

2.4 United States Insomnia Drugs Market Competitive Situation and Trends

2.4.1 United States Insomnia Drugs Market Concentration Rate

2.4.2 United States Insomnia Drugs Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers Insomnia Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 United States Insomnia Drugs Sales (Volume) and Revenue (Value) by Region (2012-2017)

3.1 United States Insomnia Drugs Sales and Market Share by Region (2012-2017)

3.2 United States Insomnia Drugs Revenue and Market Share by Region (2012-2017)

3.3 United States Insomnia Drugs Price by Region (2012-2017)

4 United States Insomnia Drugs Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)

4.1 United States Insomnia Drugs Sales and Market Share by Type (Product Category) (2012-2017)

4.2 United States Insomnia Drugs Revenue and Market Share by Type (2012-2017)

4.3 United States Insomnia Drugs Price by Type (2012-2017)

4.4 United States Insomnia Drugs Sales Growth Rate by Type (2012-2017)

5 United States Insomnia Drugs Sales (Volume) by Application (2012-2017)

5.1 United States Insomnia Drugs Sales and Market Share by Application (2012-2017)

5.2 United States Insomnia Drugs Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Insomnia Drugs Players/Suppliers Profiles and Sales Data

6.1 Merck

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Insomnia Drugs Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Merck Insomnia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Eisai

6.2.2 Insomnia Drugs Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Eisai Insomnia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Pfizer

6.3.2 Insomnia Drugs Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Pfizer Insomnia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Sanofi

6.4.2 Insomnia Drugs Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Sanofi Insomnia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Takeda Pharmaceutical

6.5.2 Insomnia Drugs Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Takeda Pharmaceutical Insomnia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 ECR Pharmaceuticals (Valeant)

6.6.2 Insomnia Drugs Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 ECR Pharmaceuticals (Valeant) Insomnia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Vanda Pharmaceuticals

6.7.2 Insomnia Drugs Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Vanda Pharmaceuticals Insomnia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Astellas

6.8.2 Insomnia Drugs Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Astellas Insomnia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 Dainippon Sumitomo

6.9.2 Insomnia Drugs Product Category, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 Dainippon Sumitomo Insomnia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

6.10 Flynn Pharma

6.10.2 Insomnia Drugs Product Category, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 Flynn Pharma Insomnia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.10.4 Main Business/Business Overview

6.11 Johnson & Johnson

6.12 Meda

6.13 Somnus Therapeutics

6.14 Purdue Pharma

6.15 Neurim

6.16 Minerva Neurosciences

6.17 Pernix Therapeutics

6.18 SkyePharma

6.19 Paratek Pharmaceuticals

7 Insomnia Drugs Manufacturing Cost Analysis

7.1 Insomnia Drugs Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Insomnia Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Insomnia Drugs Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Insomnia Drugs Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Insomnia Drugs Market Size (Value and Volume) Forecast (2017-2022)

11.1 United States Insomnia Drugs Sales Volume, Revenue Forecast (2017-2022)

11.2 United States Insomnia Drugs Sales Volume Forecast by Type (2017-2022)

11.3 United States Insomnia Drugs Sales Volume Forecast by Application (2017-2022)

11.4 United States Insomnia Drugs Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

Figure Product Picture of Insomnia Drugs

Figure United States Insomnia Drugs Market Size (MT) by Type (2012-2022)

Figure United States Insomnia Drugs Sales Volume Market Share by Type (Product Category) in 2016

Figure Prescription Drugs Product Picture

Figure Over-the-counter Drugs Product Picture

Figure United States Insomnia Drugs Market Size (MT) by Application (2012-2022)

Figure United States Sales Market Share of Insomnia Drugs by Application in 2016

Figure Hospital Examples

Table Key Downstream Customer in Hospital

Figure Ambulatory Surgical Center Examples

Table Key Downstream Customer in Ambulatory Surgical Center

Figure Home Care Examples

Table Key Downstream Customer in Home Care

Figure United States Insomnia Drugs Market Size (Million USD) by Region (2012-2022)

Figure The West Insomnia Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest Insomnia Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Middle Atlantic Insomnia Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure New England Insomnia Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure The South of US Insomnia Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Midwest Insomnia Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Insomnia Drugs Sales (MT) and Growth Rate (2012-2022)

Figure United States Insomnia Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Insomnia Drugs Market Major Players Product Sales Volume (MT) (2012-2017)

Table United States Insomnia Drugs Sales (MT) of Key Players/Suppliers (2012-2017)

Table United States Insomnia Drugs Sales Share by Players/Suppliers (2012-2017)

Figure 2016 United States Insomnia Drugs Sales Share by Players/Suppliers

Figure 2017 United States Insomnia Drugs Sales Share by Players/Suppliers

Figure United States Insomnia Drugs Market Major Players Product Revenue (Million USD) (2012-2017)

Table United States Insomnia Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)

Table United States Insomnia Drugs Revenue Share by Players/Suppliers (2012-2017)

Figure 2016 United States Insomnia Drugs Revenue Share by Players/Suppliers

Figure 2017 United States Insomnia Drugs Revenue Share by Players/Suppliers

Table United States Market Insomnia Drugs Average Price (K USD/Kg) of Key Players/Suppliers (2012-2017)

Figure United States Market Insomnia Drugs Average Price (K USD/Kg) of Key Players/Suppliers in 2016

Figure United States Insomnia Drugs Market Share of Top 3 Players/Suppliers

Figure United States Insomnia Drugs Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers Insomnia Drugs Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers Insomnia Drugs Product Category

Table United States Insomnia Drugs Sales (MT) by Region (2012-2017)

Table United States Insomnia Drugs Sales Share by Region (2012-2017)

Figure United States Insomnia Drugs Sales Share by Region (2012-2017)

Figure United States Insomnia Drugs Sales Market Share by Region in 2016

Table United States Insomnia Drugs Revenue (Million USD) and Market Share by Region (2012-2017)

Table United States Insomnia Drugs Revenue Share by Region (2012-2017)

Figure United States Insomnia Drugs Revenue Market Share by Region (2012-2017)

Figure United States Insomnia Drugs Revenue Market Share by Region in 2016

Table United States Insomnia Drugs Price (K USD/Kg) by Region (2012-2017)

Table United States Insomnia Drugs Sales (MT) by Type (2012-2017)

Table United States Insomnia Drugs Sales Share by Type (2012-2017)

Figure United States Insomnia Drugs Sales Share by Type (2012-2017)

Figure United States Insomnia Drugs Sales Market Share by Type in 2016

Table United States Insomnia Drugs Revenue (Million USD) and Market Share by Type (2012-2017)

Table United States Insomnia Drugs Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Insomnia Drugs by Type (2012-2017)

Figure Revenue Market Share of Insomnia Drugs by Type in 2016

Table United States Insomnia Drugs Price (K USD/Kg) by Types (2012-2017)

Figure United States Insomnia Drugs Sales Growth Rate by Type (2012-2017)

Table United States Insomnia Drugs Sales (MT) by Application (2012-2017)

Table United States Insomnia Drugs Sales Market Share by Application (2012-2017)

Figure United States Insomnia Drugs Sales Market Share by Application (2012-2017)

Figure United States Insomnia Drugs Sales Market Share by Application in 2016

Table United States Insomnia Drugs Sales Growth Rate by Application (2012-2017)

Figure United States Insomnia Drugs Sales Growth Rate by Application (2012-2017)

Table Merck Basic Information List

Table Merck Insomnia Drugs Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)

Figure Merck Insomnia Drugs Sales Growth Rate (2012-2017)

Figure Merck Insomnia Drugs Sales Market Share in United States (2012-2017)

Figure Merck Insomnia Drugs Revenue Market Share in United States (2012-2017)

Table Eisai Basic Information List

Table Eisai Insomnia Drugs Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)

Figure Eisai Insomnia Drugs Sales Growth Rate (2012-2017)

Figure Eisai Insomnia Drugs Sales Market Share in United States (2012-2017)

Figure Eisai Insomnia Drugs Revenue Market Share in United States (2012-2017)

Table Pfizer Basic Information List

Table Pfizer Insomnia Drugs Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)

Figure Pfizer Insomnia Drugs Sales Growth Rate (2012-2017)

Figure Pfizer Insomnia Drugs Sales Market Share in United States (2012-2017)

Figure Pfizer Insomnia Drugs Revenue Market Share in United States (2012-2017)

Table Sanofi Basic Information List

Table Sanofi Insomnia Drugs Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)

Figure Sanofi Insomnia Drugs Sales Growth Rate (2012-2017)

Figure Sanofi Insomnia Drugs Sales Market Share in United States (2012-2017)

Figure Sanofi Insomnia Drugs Revenue Market Share in United States (2012-2017)

Table Takeda Pharmaceutical Basic Information List

Table Takeda Pharmaceutical Insomnia Drugs Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)

Figure Takeda Pharmaceutical Insomnia Drugs Sales Growth Rate (2012-2017)

Figure Takeda Pharmaceutical Insomnia Drugs Sales Market Share in United States (2012-2017)

Figure Takeda Pharmaceutical Insomnia Drugs Revenue Market Share in United States (2012-2017)

Table ECR Pharmaceuticals (Valeant) Basic Information List

Table ECR Pharmaceuticals (Valeant) Insomnia Drugs Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)

Figure ECR Pharmaceuticals (Valeant) Insomnia Drugs Sales Growth Rate (2012-2017)

Figure ECR Pharmaceuticals (Valeant) Insomnia Drugs Sales Market Share in United States (2012-2017)

Figure ECR Pharmaceuticals (Valeant) Insomnia Drugs Revenue Market Share in United States (2012-2017)

Table Vanda Pharmaceuticals Basic Information List

Table Vanda Pharmaceuticals Insomnia Drugs Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)

Figure Vanda Pharmaceuticals Insomnia Drugs Sales Growth Rate (2012-2017)

Figure Vanda Pharmaceuticals Insomnia Drugs Sales Market Share in United States (2012-2017)

Figure Vanda Pharmaceuticals Insomnia Drugs Revenue Market Share in United States (2012-2017)

Table Astellas Basic Information List

Table Astellas Insomnia Drugs Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)

Figure Astellas Insomnia Drugs Sales Growth Rate (2012-2017)

Figure Astellas Insomnia Drugs Sales Market Share in United States (2012-2017)

Figure Astellas Insomnia Drugs Revenue Market Share in United States (2012-2017)

Table Dainippon Sumitomo Basic Information List

Table Dainippon Sumitomo Insomnia Drugs Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)

Figure Dainippon Sumitomo Insomnia Drugs Sales Growth Rate (2012-2017)

Figure Dainippon Sumitomo Insomnia Drugs Sales Market Share in United States (2012-2017)

Figure Dainippon Sumitomo Insomnia Drugs Revenue Market Share in United States (2012-2017)

Table Flynn Pharma Basic Information List

Table Flynn Pharma Insomnia Drugs Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)

Figure Flynn Pharma Insomnia Drugs Sales Growth Rate (2012-2017)

Figure Flynn Pharma Insomnia Drugs Sales Market Share in United States (2012-2017)

Figure Flynn Pharma Insomnia Drugs Revenue Market Share in United States (2012-2017)

Table Johnson & Johnson Basic Information List

Table Meda Basic Information List

Table Somnus Therapeutics Basic Information List

Table Purdue Pharma Basic Information List

Table Neurim Basic Information List

Table Minerva Neurosciences Basic Information List

Table Pernix Therapeutics Basic Information List

Table SkyePharma Basic Information List

Table Paratek Pharmaceuticals Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Insomnia Drugs

Figure Manufacturing Process Analysis of Insomnia Drugs

Figure Insomnia Drugs Industrial Chain Analysis

Table Raw Materials Sources of Insomnia Drugs Major Players/Suppliers in 2016

Table Major Buyers of Insomnia Drugs

Table Distributors/Traders List

Figure United States Insomnia Drugs Sales Volume (MT) and Growth Rate Forecast (2017-2022)

Figure United States Insomnia Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure United States Insomnia Drugs Price (K USD/Kg) Trend Forecast (2017-2022)

Table United States Insomnia Drugs Sales Volume (MT) Forecast by Type (2017-2022)

Figure United States Insomnia Drugs Sales Volume (MT) Forecast by Type (2017-2022)

Figure United States Insomnia Drugs Sales Volume (MT) Forecast by Type in 2022

Table United States Insomnia Drugs Sales Volume (MT) Forecast by Application (2017-2022)

Figure United States Insomnia Drugs Sales Volume (MT) Forecast by Application (2017-2022)

Figure United States Insomnia Drugs Sales Volume (MT) Forecast by Application in 2022

Table United States Insomnia Drugs Sales Volume (MT) Forecast by Region (2017-2022)

Table United States Insomnia Drugs Sales Volume Share Forecast by Region (2017-2022)

Figure United States Insomnia Drugs Sales Volume Share Forecast by Region (2017-2022)

Figure United States Insomnia Drugs Sales Volume Share Forecast by Region in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources